Dentium CO., LTD (KRX:145720)
49,150
-700 (-1.40%)
Dec 10, 2025, 3:30 PM KST
Dentium CO., LTD Market Cap
Dentium CO., LTD has a market cap or net worth of 423.86 billion as of December 10, 2025. Its market cap has decreased by -15.40% in one year.
Market Cap
423.86B
Enterprise Value
610.05B
Revenue
356.03B
Ranking
n/a
PE Ratio
10.07
Stock Price
49,150.00
Market Cap Chart
Since March 15, 2017, Dentium CO., LTD's market cap has increased from 295.94B to 423.86B, an increase of 43.22%. That is a compound annual growth rate of 4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 429.90B | -19.86% |
| Dec 30, 2024 | 536.41B | -52.52% |
| Dec 28, 2023 | 1.13T | 31.00% |
| Dec 29, 2022 | 862.39B | 43.27% |
| Dec 30, 2021 | 601.95B | 69.83% |
| Dec 30, 2020 | 354.44B | -23.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.07T |
| Celltrion | 40.98T |
| ALTEOGEN | 24.44T |
| ABL Bio | 11.19T |
| SK Biopharmaceuticals | 10.66T |
| Yuhan | 8.65T |
| LigaChem Biosciences | 6.88T |
| Peptron | 6.54T |